EXoZymes Inc EXOZ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $6.22
- Day Range
- $5.25–6.28
- 52-Week Range
- $0.00–18.40
- Bid/Ask
- $5.30 / $6.93
- Shares Outstanding
- 9.28M
- Market Cap
- $55.87M
- Volume/Avg
- 8,144 / 7,926
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 32
- Website
- https://www.exozymes.com
Valuation
|
Metric
|
EXOZ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 33.40 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
EXOZ
|
|---|---|
Quick Ratio | 1.10 |
Current Ratio | 1.32 |
Interest Coverage | — |
Quick Ratio
EXOZ
Profitability
|
Metric
|
EXOZ
|
|---|---|
Return on Assets (Normalized) | −96.68% |
Return on Equity (Normalized) | −142.41% |
Return on Invested Capital (Normalized) | −118.70% |
Return on Assets
EXOZ
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|BBM%n%< | LOCK|^ZjD | $123B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|C>$?<#% | LOCK|Q>Pv | $71B | |||
| argenx SE ADR
ARGX
| LOCK|vVb^ZB | LOCK|!Tp | $54B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|W##&cn | LOCK|?$ | $36B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|%@!<s< | LOCK|&qs!K | $36B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|Y#wD%qZ | LOCK|<@QY | $26B | |||
| Moderna Inc
MRNA
| LOCK|Fy%FPw^ | LOCK|?v% | $25B | |||
| Incyte Corp
INCY
| LOCK|h!skS&< | LOCK|&< | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|#gPW@d^ | LOCK|<< | $23B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|p>?#QY | LOCK|@lG | $16B |
United States